UPS buys Hungarian pharma firm
UPS has announced it will acquire Hungary-based pharmaceutical logistics company Cemelog in order to strengthen its healthcare business in Europe, as part of a global growth and investment strategy ... Published:  29 April 2013

Awards to recognise achievement in Health & Pharmaceuticals
Healthcare and the pharmaceuticals industry play a critical role in people’s lives and the organisations supplying their products are increasingly looking for innovative and modern solutions to get the best out of their supply chains, enabling them to... Published:  16 April 2013

New European supply chain projects director for Omega Pharma
Sue Austin has been appointed as global healthcare company Omega Pharma’s European supply chain projects director... Published:  08 March 2013

Tricky operations
Getting closer to the customer is the goal of most organisations and this is particularly true for manufacturers of implantable medical devices. Although there is considerable product innovation to provide better clinical results, the supply... Published:  30 May 2008

Efficiency is on the cards
The drive for efficiency in physical supply chains has benefited firms prepared to adopt new models and technology. Meanwhile, the financial supply chain has ground to make up if it is to avoid becoming a significant bottleneck. ... Published:  01 April 2008

The English patient
Healthcare is a highly political subject. When the UK’s NHS outsourced its supply chain to a logistics services company close scrutiny ensued. But the stakes are high – assurances were given that savings of €127million would bemade each year for ten... Published:  30 May 2008

What's to be heard at ESC 2008
The sixth in the series, the Extended Supply Chain 2008 conference looks set to surpass all others to date. ... Published:  01 February 2008

Balancing risk
Two major humanitarian disasters - the Burmese cyclone and the Chinese earthquake - provided a sombre backdrop to ''Supply Chain Standard''s Roundtable discussion on supply chain risk. But as Dave Food, business development director from the meeting's ... Published:  30 May 2008

Taking the trial out of pharmaceutical testing
Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and - given time limitations on patents - the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most... Published:  01 November 2007